Mariani Silvia, Wang I-Wen, van Bussel Bas C T, Heuts Samuel, Wiedemann Dominik, Saeed Diyar, van der Horst Iwan C C, Pozzi Matteo, Loforte Antonio, Boeken Udo, Samalavicius Robertas, Bounader Karl, Hou Xiaotong, Bunge Jeroen J H, Buscher Hergen, Salazar Leonardo, Meyns Bart, Herr Daniel, Matteucci Sacha, Sponga Sandro, Ramanathan Kollengode, Russo Claudio, Formica Francesco, Sakiyalak Pranya, Fiore Antonio, Camboni Daniele, Raffa Giuseppe Maria, Diaz Rodrigo, Jung Jae-Seung, Belohlavek Jan, Pellegrino Vin, Bianchi Giacomo, Pettinari Matteo, Barbone Alessandro, Garcia José P, Shekar Kiran, Whitman Glenn, Lorusso Roberto
Cardio-Thoracic Surgery Department, Maastricht University Medical Center, and Cardiovascular Research Institute Maastricht (CAIRM), Maastricht, The Netherlands.
Division of Cardiac Surgery, Memorial Healthcare System, Hollywood, Calif.
J Thorac Cardiovasc Surg. 2023 Dec;166(6):1670-1682.e33. doi: 10.1016/j.jtcvs.2023.04.042. Epub 2023 May 17.
Postcardiotomy extracorporeal membrane oxygenation (ECMO) can be initiated intraoperatively or postoperatively based on indications, settings, patient profile, and conditions. The topic of implantation timing only recently gained attention from the clinical community. We compare patient characteristics as well as in-hospital and long-term survival between intraoperative and postoperative ECMO.
The retrospective, multicenter, observational Postcardiotomy Extracorporeal Life Support (PELS-1) study includes adults who required ECMO due to postcardiotomy shock between 2000 and 2020. We compared patients who received ECMO in the operating theater (intraoperative) with those in the intensive care unit (postoperative) on in-hospital and postdischarge outcomes.
We studied 2003 patients (women: 41.1%; median age: 65 years; interquartile range [IQR], 55.0-72.0). Intraoperative ECMO patients (n = 1287) compared with postoperative ECMO patients (n = 716) had worse preoperative risk profiles. Cardiogenic shock (45.3%), right ventricular failure (15.9%), and cardiac arrest (14.3%) were the main indications for postoperative ECMO initiation, with cannulation occurring after (median) 1 day (IQR, 1-3 days). Compared with intraoperative application, patients who received postoperative ECMO showed more complications, cardiac reoperations (intraoperative: 19.7%; postoperative: 24.8%, P = .011), percutaneous coronary interventions (intraoperative: 1.8%; postoperative: 3.6%, P = .026), and had greater in-hospital mortality (intraoperative: 57.5%; postoperative: 64.5%, P = .002). Among hospital survivors, ECMO duration was shorter after intraoperative ECMO (median, 104; IQR, 67.8-164.2 hours) compared with postoperative ECMO (median, 139.7; IQR, 95.8-192 hours, P < .001), whereas postdischarge long-term survival was similar between the 2 groups (P = .86).
Intraoperative and postoperative ECMO implantations are associated with different patient characteristics and outcomes, with greater complications and in-hospital mortality after postoperative ECMO. Strategies to identify the optimal location and timing of postcardiotomy ECMO in relation to specific patient characteristics are warranted to optimize in-hospital outcomes.
心脏术后体外膜肺氧合(ECMO)可根据适应症、设备、患者情况和病情在术中或术后启动。植入时机这一话题直到最近才引起临床界的关注。我们比较术中与术后ECMO患者的特征、住院期间及长期生存率。
回顾性、多中心、观察性的心脏术后体外生命支持(PELS-1)研究纳入了2000年至2020年间因心脏术后休克而需要ECMO的成人患者。我们比较了在手术室接受ECMO(术中)的患者与在重症监护病房接受ECMO(术后)的患者的住院期间及出院后结局。
我们研究了2003例患者(女性:41.1%;中位年龄:65岁;四分位间距[IQR],55.0-72.0)。术中ECMO患者(n = 1287)与术后ECMO患者(n = 716)相比,术前风险状况更差。心源性休克(45.3%)、右心室衰竭(15.9%)和心脏骤停(14.3%)是术后启动ECMO的主要适应症,插管在(中位)1天(IQR,1-3天)后进行。与术中应用相比,接受术后ECMO的患者出现更多并发症、心脏再次手术(术中:19.7%;术后:24.8%,P = 0.011)、经皮冠状动脉介入治疗(术中:1.8%;术后:3.6%,P = 0.026),且住院死亡率更高(术中:57.5%;术后:64.5%,P = 0.002)。在住院幸存者中,术中ECMO后的ECMO持续时间(中位,104;IQR,67.8-164.2小时)比术后ECMO(中位,139.7;IQR,95.8-192小时,P < 0.001)短,而两组出院后的长期生存率相似(P = 0.86)。
术中与术后ECMO植入与不同的患者特征和结局相关,术后ECMO后的并发症和住院死亡率更高。有必要制定策略,根据特定患者特征确定心脏术后ECMO的最佳位置和时机,以优化住院结局。